3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
14
Lung Neoplasms
10
Colorectal Neoplasms
8
Prostatic Neoplasms
7
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Lymphoma
3
Colonic Neoplasms
3
Urinary Bladder Neoplasms
2
Skin Carcinoma
2
Melanoma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Hematologic Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Anatomic Stage I Breast Cancer AJCC v8
2
Advanced Malignant Solid Neoplasm
2
Triple Negative Breast Neoplasms
1
Spondylitis, Ankylosing
1
Sleep Wake Disorders
1
Rectal Neoplasms
1
Pyloric Stenosis, Hypertrophic
1
Psoriasis
1
Prostate
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Papillomavirus Infections
1
Pain
1
Overweight
1
Obesity-Related Malignant Neoplasm
1
Obesity
1
Interventions
pembrolizumab
29
Cisplatin
19
Carboplatin
13
Cetuximab
12
Radiotherapy
10
Paclitaxel
9
Surveys and Questionnaires
8
Docetaxel
6
Radiotherapy, Intensity-Modulated
5
Surgical Procedures, Operative
4
Standard of Care
4
130-nm albumin-bound paclitaxel
4
dostarlimab
3
Therapeutics
3
Nivolumab
3
Fluorouracil
3
Cyclophosphamide
3
Chemoradiotherapy
3
Blood Specimen Collection
3
Albumin-Bound Paclitaxel
3
toripalimab
2
nimotuzumab
2
fludarabine
2
durvalumab
2
atezolizumab
2
abemaciclib
2
X-Rays
2
Taxes
2
Radiosurgery
2
Radiation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Head and Neck Neoplasms
×
Early Intervention, Educational
×
90 days
×
Clear all
No trials found.